Zuzanna Rybka

Zuzanna Rybka

Auto-generated profile, based on publicly available information

Zuzanna Rybka


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
JŻJulia Żak
Julia Żak
MSMonika StęPińska
Monika StęPińska
MOMarta Omiecińska
Marta Omiecińska
AMAlicja Maciejewska
Alicja Maciejewska
MKMaja Kaczor
Maja Kaczor
JWJakub Winiarczyk
Jakub Winiarczyk
Background: Artificial intelligence (AI) is rapidly moving from theoretical research into daily hospital operations. While AI promises to improve diagnostic speed and reduce administrative burnout, its real-world success depends on how well it integrates into complex clinical workflows. This review evaluates the practical impact of both discriminative and generative AI on modern healthcare delivery. Methods: We conducted a targeted literature search using PubMed and Semantic Scholar (via Consensus AI) for research published between January 2018 and March 2026. We structured this work as a critical narrative review to focus specifically on the practical challenges and successes of AI in real-world hospital settings. After screening for clinical relevance and the presence of deployment data, we selected 21 peer-reviewed articles for final inclusion. Results: The evidence shows that discriminative AI significantly improves speed in acute care, particularly in sepsis forecasting and stroke triage. Newer models are also showing success in evaluating surgical risks from ECGs and tracking traumatic brain injuries. However, these tools often face challenges like "alert fatigue" and data bias. On the administrative side, generative AI—such as ambient clinical scribes—is successfully reducing documentation time and improving billing accuracy. We found that the success of these tools depends on "Human-in-the-Loop" models and mathematical explainability frameworks, like SHAP values, which help doctors understand and trust AI decisions. Conclusion: AI is becoming a necessary requirement for modern medicine, not just an optional upgrade. By offloading high-volume data tasks to machines, AI can help return the physician’s focus to direct patient care. Future success depends on using protocols that ensure algorithmic transparency and prevent automation bias, ensuring the doctor remains the final authority in clinical decisions.

11 August 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
ZRZuzanna Rybka
Zuzanna Rybka
MKMonika Kamińska
Monika Kamińska
KMKatarzyna Moczyróg
Katarzyna Moczyróg
PKPatrycja Karnas-Bogacka
Patrycja Karnas-Bogacka
AUAdrian Uchto
Adrian Uchto
KPKarolina Alicja Palacz
Karolina Alicja Palacz
Introduction. Hashimoto's disease (HD) is the main cause of hypothyroidism in countries where there is no iodine deficiency in the diet. Characteristic antibodies for it are anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin (anti-Tg) and their level positively correlates with the severity of HD. Whereas its occurrence is related to genetic, environmental and existential factors. Aim of study. The aim of this study was to analyze dietary factors (protein, fat, vitamin D, iodine, selenium, gluten) and intestinal microbiota on the risk of developing Hashimoto's disease and the influence of each of these factors on its course. Materials and methods. More than 90 articles addressing these issues were analyzed. They were found using the PubMed search engine, and the time frame of these publications covered the last 10 years. Results. Excess iodine is the most important environmental factor influencing the development of Hashimoto's disease. Also, selenium deficiency contributes to the development of HD. On the other hand, the concentration of vitamin D is lower in patients with Hashimoto's disease than in the general population. Furthermore, Vitamin D supplementation reduces the concentration of anti-Tg antibodies. In addition, different types of dietary fat affect thyroid hormone levels differently and a deficiency of protein in the diet causes an increase in TSH and a decrease in thyroid hormones. Moreover, changes in the gut microbiome have been observed in people suffering from Hashimoto's disease. Conclusions. The risk of developing Hashimoto's disease can be increased and decreased by diet and diet allows for the modification of hormone levels in the hypothalamus-pituitary-thyroid axis.

4 May 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MOMarta Omiecińska
Marta Omiecińska
MSMonika StęPińska
Monika StęPińska
AMAlicja Maciejewska
Alicja Maciejewska
MKMaja Kaczor
Maja Kaczor
WTWeronika Trynkiewicz
Weronika Trynkiewicz
JWJakub Winiarczyk
Jakub Winiarczyk
The rapid expansion of digital health technologies has transformed how people seek, interpret, and use medical information. Tools supporting self-diagnosis—such as online symptom checkers, AI-based chatbots, wearable biosensors, and mobile health applications—are now widely used across healthcare systems. This review examines the clinical, ethical, and societal implications of these developments. A structured search of PubMed/MEDLINE, Google Scholar, and the Cochrane Library identified peer-reviewed studies published between 2010 and 2025 evaluating consumer-oriented diagnostic technologies. Eligible studies addressed diagnostic performance, behavioral outcomes, regulation, health literacy, and equity. Due to methodological heterogeneity, results were synthesized narratively. Evidence suggests that digital self-diagnosis tools provide several benefits, including improved access to health information, earlier symptom assessment, triage support, and greater patient engagement. These advantages may be particularly important in resource-limited settings and during periods of healthcare system strain. However, notable concerns remain. Diagnostic accuracy varies considerably, and triage advice may be overly cautious or occasionally inappropriate. Additional risks include increased health anxiety, exposure to misinformation, data privacy issues, and the potential to exacerbate existing social inequalities. Moreover, the current evidence base is uneven, with limited real-world validation and insufficient research on long-term behavioral and professional impacts. Digital self-diagnosis represents a lasting structural change rather than a temporary trend. Its effective integration into healthcare systems will require stronger regulatory oversight, greater investment in digital health literacy, and interdisciplinary research addressing clinical effectiveness, ethical governance, and equity. Careful management is necessary to ensure that technological innovation strengthens—rather than undermines—the quality and fairness of medical care.

22 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MKMaciej Kaszyński
Maciej Kaszyński
BSBarbara Stankiewicz
Barbara Stankiewicz
AKAleksandra Kalicka
Aleksandra Kalicka
KMKarolina Mikołap
Karolina Mikołap
MOMonika Olszanecka
Monika Olszanecka
IPIzabela Pągowska-Klimek
Izabela Pągowska-Klimek
Background: Opioids remain the most effective component of systemic analgesia and are considered safe and beneficial when administered at the lowest effective dose. Nevertheless, their potential adverse effects may diminish the quality of the postoperative period or, in some cases, lead to life-threatening complications. This analysis examines whether the mandatory implementation of a standardised protocol offers opioid-sparing potential. Methods: In this single-centre retrospective cohort study, intraoperative opioid consumption during laparoscopic appendectomy was compared between patients anaesthetised according to a standardised protocol (n1 = 132) and those managed at clinicians’ discretion in line with good medical practice (n2 = 212). Length of hospital stay and use of intraoperative non-opioid analgesics were also assessed. Results: The total fentanyl dose administered during anaesthesia was significantly lower in the standardised protocol cohort compared to the cohort without a protocol: 3.13 μg·kg−1 (IQR: 2.98–4.08) vs. 5.19 μg·kg−1 (IQR: 3.89–6.67), p < 0.001. In the protocol cohort, the percentage of patients who received acetaminophen and metamizole was significantly higher—increasing by 57% and 23%, respectively (p < 0.001). No significant inter-cohort difference was observed in terms of length of hospital stay. Conclusions: The use of a mandatory anaesthetic protocol based on a multimodal approach had an opioid-sparing effect in children undergoing laparoscopic appendectomy. This retrospective analysis was approved by the Ethics Committee of the Medical University of Warsaw (identifier: AKBE/118/2025; date of acceptance: 12 May 2025), and the primary trial was registered in the U.S. National Library of Medicine Clinical Trials Registry (registration number: NCT05238506; date of first registration: 14 February 2022).

26 May 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
ZRZuzanna Rybka
Zuzanna Rybka
AMAlicja Maciejewska
Alicja Maciejewska
MKMaja Kaczor
Maja Kaczor
MSMonika StęPińska
Monika StęPińska
MOMarta Omiecińska
Marta Omiecińska
MŚMaja Śmigielska
Maja Śmigielska
Vitamin D plays a well-known role in calcium and phosphate homeostasis. Recent findings also indicate many extraskeletal effects. Studies have shown that a vitamin D deficiency has been associated with chronic conditions in musculoskeletal, cardiovascular, neurological and immune systems. There have been multiple national and international guidelines considering the problem of vitamin D supplementation and treatment. Recommendations for vitamin D prophylaxis and treatment show variability which may result in confusion in clinical practice. The aim of this review is to compare diagnostic thresholds of scrum 25(OH)D levels and dosing strategies for prevention and treatment between selected vitamin D guidelines published in Poland, Central Europe and the United States of America. Future recommendations should integrate the results of observational studies and randomized control trials. This way they may benefit the clinicians and patients by simplifying treatment decisions and improving clinical outcomes.

23 April 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
ELEmilia Lenkiewicz
Emilia Lenkiewicz
AMAlicja Maciejewska
Alicja Maciejewska
MSMonika StęPińska
Monika StęPińska
MOMarta Omiecińska
Marta Omiecińska
MKMaja Kaczor
Maja Kaczor
JWJakub Winiarczyk
Jakub Winiarczyk
Background: Metabolic disorders, particularly type 2 diabetes and obesity, represent one of the greatest public health challenges of the 21st century. In response to the limitations and side effects of conventional pharmacotherapy, many patients are seeking natural alternatives. Berberine, a traditional medicinal plant compound, has become increasingly popular on social media under the label “Nature’s Ozempic.” Objective: This narrative review provides a comprehensive synthesis of berberine in metabolic disorders. It examines its molecular mechanisms, clinical evidence, safety profile, pharmacological interactions, and the public health consequences of its rapid rise on social media. Methods: A targeted literature search was conducted in PubMed, Scopus, Web of Science, and Google Scholar. Priority was given to randomised controlled trials, meta-analyses, mechanistic studies, and recent publications analysing social media trends. The articles published between 2009 and 2026 were primarily included. Main Findings: Berberine acts through multiple pathways, most notably AMPK activation, modulation of the gut microbiota, and anti-inflammatory effects. Clinical studies show mild but consistent improvements in glycemic control, insulin sensitivity, and lipid parameters, particularly in patients with type 2 diabetes or metabolic syndrome. Its impact on body weight and visceral fat is generally limited. Short-term safety is acceptable, with mainly mild gastrointestinal side effects, although potential interactions with cytochrome P450 enzymes and P-glycoprotein have been documented. Conclusions: Berberine may serve as a useful adjunctive option in selected patients, but it cannot replace standard therapies such as metformin or statins. Its growing popularity on social media has encouraged widespread self-medication, raising concerns about safety and unrealistic expectations. Larger, longer-term, and more diverse studies are needed to define its true clinical value and long-term safety.